Evidence map›Paper›PMID 21746883›Full record

ArticleMolecular and cellular biology2011

Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis.

Krishna M Irrinki, Karthik Mallilankaraman, Roshan J Thapa, Harish C Chandramoorthy, Frank J Smith, Neelakshi R Jog, Rajesh Kumar Gandhirajan, Steven G Kelsen, Steven R Houser, Michael J May and 2 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Mitochondria and cell death.Nature cell biology · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Mitochondrial Mechanisms of Necroptosis in Liver Diseases.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Krishna M IrrinkiDepartment of Biochemistry, Temple University, Philadelphia, PA 19140, USA.
Karthik Mallilankaraman
Roshan J Thapa
Harish C Chandramoorthy
Frank J Smith
Neelakshi R Jog
Rajesh Kumar Gandhirajan
Steven G Kelsen
Steven R Houser
Michael J May
Siddharth Balachandran
Muniswamy Madesh
Temple University · USFox Chase Cancer Center · USUniversity of Pennsylvania · US

Funding

TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Coordination of Pathophysiologic Endothelial Cell Signaling by ROSR01HL086699 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI MUNISWAMY, MADESH · 2008 to 2018
$4.3M
Targeting NF-kB in AtherosclerosisR01HL096642 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MAY, MICHAEL J · 2011 to 2014
$1.6M
Multiphoton Confocal Microscopy for Biomedical ResearchS10RR027327 · NCRR · TEMPLE UNIV OF THE COMMONWEALTH · PI MUNISWAMY, MADESH · 2010 to 2010
$500k
NCI NIH HHS T32 CA009035NCRR NIH HHS 1S10RR027327-01NCRR NIH HHS S10 RR027327NHLBI NIH HHS HL086699-01A2S1NHLBI NIH HHS R01 HL086699
6 · The paper itself

Abstract

Necroptosis represents a form of alternative programmed cell death that is dependent on the kinase RIP1. RIP1-dependent necroptotic death manifests as increased reactive oxygen species (ROS) production in mitochondria and is accompanied by loss of ATP biogenesis and eventual dissipation of mitochondrial membrane potential. Here, we show that tumor necrosis factor alpha (TNF-α)-induced necroptosis requires the adaptor proteins FADD and NEMO. FADD was found to mediate formation of the TNF-α-induced pronecrotic RIP1-RIP3 kinase complex, whereas the IκB Kinase (IKK) subunit NEMO appears to function downstream of RIP1-RIP3. Interestingly, loss of RelA potentiated TNF-α-dependent necroptosis, indicating that NEMO regulates necroptosis independently of NF-κB. Using both pharmacologic and genetic approaches, we demonstrate that the overexpression of antioxidants alleviates ROS elevation and necroptosis. Finally, elimination of BAX and BAK or overexpression of Bcl-x(L) protects cells from necroptosis at a later step. These findings provide evidence that mitochondria play an amplifying role in inflammation-induced necroptosis.

Indexed as

AnimalsApoptosisbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinBlotting, WesternFas-Associated Death Domain ProteinFlow CytometryGene Knockout TechniquesGTPase-Activating ProteinsImmunoprecipitationIntracellular Signaling Peptides and ProteinsMembrane Potential, MitochondrialMiceMitochondriaNecrosisNF-kappa Bbcl-2-Associated X Proteinbcl-2 Homologous Antagonist-Killer ProteinFadd protein, mouseFas-Associated Death Domain ProteinGTPase-Activating ProteinsIntracellular Signaling Peptides and ProteinsNEMO protein, mouseNF-kappa BRalbp1 protein, mouseReactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine KinasesRela protein, mouseRipk3 protein, mouseTranscription Factor RelATumor Necrosis Factor-alpha

Identifiers

PMID21746883
PMCPMC3165716
OpenAlexW2115296770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.